At-home brain stimulation therapy can safely and effectively treat severe to moderate depression, a new clinical trial shows.

Glioblastomas are aggressive brain tumors with a median survival time of less than 22 months despite standard therapy including surgery, irradiation, and chemotherapy.

A promising ALS drug may help combat glioblastoma by targeting the cancerous stem cells that fuel tumor growth.

Glioblastomas are aggressive brain tumors with a median survival time of less than 22 months despite standard therapy ...

Eve is a joyful, adventurous two-year-old "with a smile that lights up every room"Her parents describe her as a “bright ...

Glioblastomas are aggressive brain tumors with a median survival time of less than 22 months despite standard therapy including surgery, irradiation ...

The British Citizen Youth Award, now in its ninth year, honoured 21 young people yesterday from across the UK that have made ...

Throughout his sports career, Pautsch remained a sports fan. He cited covering the NFL and NBA Drafts, going to the Super Bowl, and being a torch bearer for the 2002 Olympic Games in Salt Lake City as ...

Scientists were able to treat a "macular hole" in a monkey, helping to restore the animal's vision thanks to human stem cells ...

CLD-101 is a novel stem cell-based treatment that delivers oncolytic viruses to tumors, which may benefit patients with newly ...

July 9, 2024 — A team of researchers has identified and located a population of stem-like cells ... New Research Platform Assesses Brain Cancer Mutations During Surgery May 30, 2024 — Brain ...

Damage to the brainstem could be behind the physical and psychological effects of Long COVID, a new study suggests.